Established drugs were repurposed, “me-too” drugs were approved, and even the few new biological approaches lacked clinical ...

Here are five things to know. 1. Fifteen states have filed legislation seeking to boost transparency surrounding drug prices this year, according to the report, which cites data from the National ...

Please provide your email address to receive an email when new articles are posted on . Cancer drugs that received accelerated approval gained regular approval faster when their confirmatory trials ...